SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-18-222562
Filing Date
2018-07-20
Accepted
2018-07-20 16:26:18
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d548117ds3.htm S-3 290683
2 EX-4.4 d548117dex44.htm EX-4.4 260703
3 EX-4.7 d548117dex47.htm EX-4.7 271797
4 EX-5.1 d548117dex51.htm EX-5.1 14930
5 EX-23.2 d548117dex232.htm EX-23.2 2582
6 GRAPHIC g548117g70x59.jpg GRAPHIC 141678
  Complete submission text file 0001193125-18-222562.txt   1037175
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-226266 | Film No.: 18962746
SIC: 2834 Pharmaceutical Preparations